INTRODUCTION
The learning of new motor skills leads to the genesis of postsynaptic dendritic spines in the motor cortex, and the retention of motor memory is associated with the maintenance of these learning-related new spines (Cichon and Gan, 2015; Xu et al., 2009 Xu et al., , 2012 Yang et al., 2009 Yang et al., , 2014 . Under pathological conditions such as those in Parkinson disease (PD), dendritic spines in the motor cortex present instability and high levels of turnover (Guo et al., 2015) . Agreeing with these findings, functional magnetic resonance imaging studies reveal pathological hyperactivity in the motor cortex of patients with PD (Pelled et al., 2002; Sabatini et al., 2000; Yu et al., 2007) . Such evidence suggests dysfunctions of the motor cortex in motor learning impairments (Guo et al., 2015; Sabatini et al., 2000) . Therefore, further studies for the relationship among synaptic activity, spine activity, and motor function may provide implications for the intervention of motor disorders.
Many lines of evidence indicate that the generation and propagation of Ca 2+ spikes in pyramidal neuron dendrites coordinate synaptic activity and facilitate synaptic potentiation and/or depotentiation (Cichon and Gan, 2015; Weber et al., 2016) . Dendritic Ca 2+ spikes participate in the strengthening and/or remodeling of dendritic spines during both development and motor learning , whereas aberrant dendritic activity is associated with synaptic depotentiation in the diseased brain (Bai et al., 2017) . The generation of Ca 2+ spikes is heavily regulated by local inhibitory interneurons, which also play an important role in modulating structural synaptic changes in pyramidal cells (Hattori et al., 2017) . In Alzheimer disease (AD), dysfunction of somatostatin-expressing inhibitory interneurons (SST-INs) results in progressive hippocampal synapse loss (Schmid et al., 2016) . Following repeated stress in mice, decreased activity of parvalbuminexpressing inhibitory interneurons causes a high rate of dendritic spine elimination in the somatosensory cortex (Chen et al., 2018) . In the motor cortex, a recent study showed that SST-INs are tightly correlated with learning-induced activities of pyramidal neurons (Adler et al., 2019) . However, no study has investigated the involvement of SST-INs under pathological conditions.
In this study, we generated an acute motor deficit model by introducing a single dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which led to impaired motor memory retention. In vivo imaging of the motor cortex revealed enhanced elimination of learning-related dendritic spines, increased pyramidal neuron dendritic activity, as well as decreased activities of SST-INs. Activation of SST-INs in the motor cortex restored dendritic Ca 2+ activity and synaptic stability and improved motor skill retention. Our results suggest that targeting SST-INs may help to relieve MPTP-induced cortical dysfunction and motor deficits.
RESULTS

Dendritic Spine Instability and Motor Memory Deficits Induced by Single MPTP Infusion
We repeatedly imaged fluorescently labeled dendritic spines of layer 5 pyramidal neurons (L5PRNs) in the primary motor cortex using transcranial two-photon microscopy ( Figure 1A) . Results showed that a single intraperitoneal (i.p.) injection of MPTP (30 mg/kg) caused a 2-fold increase in dendritic spine turnover within 4-24 h in 1-month-old mice (MPTP versus vehicle, all in %, 4 h, 9.0 G 0.54 versus 4.4 G 0.58; 24 h, 18 .2 G 0.95 versus 10.4 G 0.74; p < 0.05 by t test in both cases; Figures 1B and 1C) . The rates of spine formation and elimination were both higher in MPTP-treated mice than those in vehicle-treated control mice (MPTP versus vehicle, all in %, elimination: 4 h, 4.2 G 0.36 versus 2.5 G 0.40; 24 h, 8.0 G 0.63 versus 4.2 G 0.36; formation: 4 h, 5.3 G 0.40 versus 1.9 G 0.27; 24 h, 10.2 G 0.57 versus 4.8 G 0.39; p < 0.05 by t test in all comparison pairs). These results indicate that MPTP has potent effects on dendritic spine dynamics in the cortex.
Previous studies have shown that motor learning induces the rapid formation of new spines in the motor cortex, and the persistence of these new spines associated with motor learning is critical for motor memory retention (Yang et al., 2009) . We next investigated whether MPTP similarly altered the dynamics of motor learning-induced new spines ( Figure 1D ). We trained 1-month-old mice to run on an accelerating rotarod or perform a beam walking task, and immediately after motor skill learning, mice were treated with MPTP. Consistent with previous studies Xu et al., 2009; Yang et al., 2009 Yang et al., , 2014 , new spine formation increased significantly within 8 h after motor training when compared with untrained controls (all in %, nonlearning, 4.4 G 0.5; beam learning, 6.2 G 0.3; rotarod learning, 6.8 G 0.4; p < 0.01 by t test for both comparison pairs; Figures 1E and 1F ). We found that among new spines formed within 8 h after motor training, fewer spines persisted over next 4 h (8-12) or 16 h (8-24) in the MPTP-treated mice when compared with vehicle-treated controls (p < 0.01 by t test for both rotarod and beam walking, Figures 1G-1I ). Furthermore, motor performance improvement was lower in MPTP-treated mice 1 day or 4 days after motor training (p < 0.05 by t test for both 1 day and 4 days, Figures 1J and 1K ). There was a significant correlation between the percentages of motor training-related persistent new spines and motor skill performance improvement (Pearson correlation, rotarod learning, r = 0.78; p = 0.0016; beam learning, r = 0.69; p = 0.0058; Figures 1L  and 1M ). Together, these results demonstrate dendritic spine instability and impaired motor memory retention by single MPTP administration.
Increased Ca 2+ Spike Generation in Apical Tuft Dendrites of Pyramidal Neurons
Previous studies have correlated dendritic spine dynamics with the dendritic activity of pyramidal neurons (Cichon and Gan, 2015; Weber et al., 2016) . To study cortical activity in MPTP-treated mice, we performed in vivo Ca 2+ imaging in apical tuft branches of L5PRNs ( Figure 2C ). Wild-type (WT) mice were given intracranial injection of an adeno-associated virus (AAV) delivered vector encoding the Ca 2+ indicator GCaMP6s to monitor pyramidal neuron activity ( Figure S1 ). First, the levels of Ca 2+ activity in dendritic spines exhibited a 3-fold increase in MPTP-treated mice when compared with vehicle treatment (p < 0.0001 by t test, Figures 2A and 2B ). In addition to Ca 2+ activity in spines, we also observed a substantial increase in dendritic Ca 2+ spikes following systemic MPTP injection: the number of Ca 2+ spikes in the field of view (FOV) rapidly increased within 1 h post-injection, reached the peak level at 2 h, and remained higher than the pre-injection baseline at 4 h (p < 0.0001 by two-way ANOVA; Figure 2D ). Vehicle treatment had no effects on the generation of dendritic Ca 2+ spikes ( Figures S2A and S2B ). Analyses of individual dendrites showed significantly higher Ca 2+ frequency and integrated Ca 2+ levels 2 h after MPTP injection relative to pre-injection (p < 0.0001 by two-way ANOVA; Figures 2E-2H , Video S1). The amplitudes of dendritic Ca 2+ spikes were comparable before and after MPTP injection ( Figure S2C ). These MPTP-induced dendritic Ca 2+ spikes were largely reduced in the presence of locally delivered N-methyl-D-aspartate (NMDA) receptor antagonist MK801 (p < 0.0001 by t test; Figures 2I and 2J ). These results show that MPTP injection causes an increase of dendritic spine and branch activity in pyramidal neuron tufts.
To further understand the effects of MPTP on the cortex, we topically applied MPTP (30 mM in artifical cerebrospinal fluid, aCSF) to the superficial layer of the motor cortex and performed in vivo Ca 2+ imaging on apical dendrites of L5PRNs ( Figure 3A ). We found that the number of Ca 2+ spikes in the FOV increased markedly over 30 min after MPTP local application and returned to the baseline 2 h post-washout (150 min post-MPTP) (p < 0.05 by t test, Figures 3B-3D , Video S2). Both frequency and integrated activity of dendritic Ca 2+ spikes peaked at 30 min after MPTP application and recovered to pre-injection levels 2 h post-washout (p < 0.0001 by two-way ANOVA, Figures 3E and 3F ). The amplitudes of dendritic (C) From left to right, overall spine turnover, elimination, and formation rates during 0-4 h and 0-24 h. MPTP group showed significantly higher spine plasticity (two-sample student t test; 0-4 h and 0-24 h; turnover, t 8 = 5.82, t 8 = 6.51; elimination, t 8 = 6.02, t 8 = 6.99; formation, t 8 = 3.15, t 8 = 4.07; p < 0.05 in all cases. n = 5 per group). (D) Experimental timeline of motor learning and two-photon microscopy. (E) Representative images of dendritic segments before (0) and after motor learning (8 h). (F) Spine formation rates over 0-8 h was significantly higher under learning paradigms (non-learning, n = 4; beam learning, n = 9; rotarod learning, n = 9; F (2, 19) = 7.231, p = 0.0046). (G-I) (G) Representative dendritic segments in time series before and after motor learning under various conditions. Filled arrowheads, newly formed spine at 8 h; asterisks, filopodia. (H and I) The survival rates of newly formed spines 12 and 24 h after (H) rotarod learning (8-12 h, t 7 = 5.496, p = 0.0009; 8-24 h, t 7 =5.941, p = 0.0006; n = 4 in rotarod + vehicle and n = 5 in rotarod + MPTP group) or (I) or beam walking learning (8-12 h, t 7 = 5.130, p = 0.0014; 8-24 h, t 7 = 4.050, p = 0.0049; n = 4 in beam + vehicle and n = 5 in beam + MPTP group). (J and K) Motor performance improvement 24 h and 4 days after (J) rotarod (24 h, t 7 = 4.867, p = 0.0018; 4 days, t 7 = 2.916, p = 0.0225) or (K) beam walking learning (24 h, t 7 = 4.463, p = 0.0024; 4 days, t 6 = 2.699, p = 0.0356). (L and M) Pearson correlation analysis showed that new spine survival rates (0-8-24 h) were positively correlated with performance improvement at 24 h in rotarod (r = 0.78, p = 0.0016; L) and beam walking (r = 0.69, p = 0.0058; M) assays. *p < 0.05. Data were presented as mean G SEM. Scale bar, 5 mm. 
Decreased Activity in Somatostatin-Expressing Inhibitory Interneurons
To understand the mechanisms underlying MPTP-induced dendritic activity in pyramidal neurons, we examined the activity of local inhibitory interneurons, focusing on dendritic-targeting SST-INs. These cells project their axons to the superficial layers of the cortex, where they primarily target pyramidal neuron dendrites and form inhibitory synapses (Urban-Ciecko and Barth, 2016). To determine the effects of MPTP on SST-IN activity, we used in vivo Ca 2+ imaging to examine the activity of SST-INs expressing GCaMP6s. Here, SST-IRES-Cre mice were injected with a Cre-dependent AAV-dio-GCaMP6s into the motor cortex to induce the expression of GCaMP6s specifically in . In contrast to the increased activity of dendritic spines and branches in L5PRNs (Figure 2 ), we found that 
Activation of SST-INs Reduces Dendritic Ca 2+ Spikes in MPTP-Treated Mice
Previous studies have shown that SST-INs regulate dendritic Ca 2+ spike generation in apical tuft dendrites of pyramidal neurons (Cichon et al., 2017) . To test whether the decreased SST-IN activity contributes to MPTP-induced dendritic Ca 2+ spikes in L5PRNs, we activated SST-INs in vivo by using the designer receptors exclusively activated by designer drugs (DREADD). In this experiment, we infected SST-INs in the motor cortex with AAV encoding Cre-dependent hM3Dq DREADD receptors in SST-IRES-Cre mice ( Figure 5A ). An i.p. injection of DREADD receptor ligand, clozapine-N-oxide (CNO), selectively activated hM3Dq-expressing SST-INs as reported by cFos immunostaining ( Figure 5B ). To test the effect of SST-IN activation on MPTP-induced dendritic activity in L5PRNs, we imaged GCaMP6s-expressing apical dendrites in mice expressing hM3Dq in SST-INs ( Figures 5A and S3 ). Dendritic Ca 2+ activities were measured before and after CNO injection in MPTP-treated mice. We found that activation of SST-INs substantially reduced the number of dendritic Ca 2+ spikes within 1 h and such effects persisted for at least 4 h (p < 0.0001 by two-way ANOVA, Figures 5C-5E , Video S3). Analyses of individual dendrites revealed a reduction of both Ca 2+ spikes' frequency and total integrated Ca 2+ levels after the activation of SST-INs (p < 0.001 by t test, Figures 5F and 5G ). Comparing among all the treatment groups, activation of SST-INs reduced the number of dendritic Ca 2+ spikes in MPTP-treated mice to levels that are comparable with the pre-MPTP group ( Figure S4 ). Taken together, these findings indicate that activation of SST-INs in the motor cortex is sufficient to suppress pyramidal neuron dendritic hyperexcitability induced by MPTP.
Activation of SST-INs Alleviates Dendritic Spine Instability and Motor Memory Deficits
We next investigated whether activation of SST-INs could rescue dendritic spine loss and motor memory deficits induced by acute MPTP infection. We crossed SST-IRES-Cre mice with Thy1-YFP mice and bilaterally injected Cre-dependent AAV-dio-hM3Dq-mCherry into the primary motor cortex ( Figure 6A ). Mice were trained on the accelerating rotarod motor learning task and administered MPTP and CNO 8 h after training. The cFos immunofluorescent staining showed that a single injection of CNO activated more than 75% of hM3Dq-expressing cells ( Figure 6B ). When dendritic spine plasticity was examined, we found that CNO treatment significantly increased the survival rates of learning-induced new spines in the motor cortex (p < 0.01 by t test for both 8-12 h and 8-24 h, Figures 6C and 6D ). Furthermore, CNO-treated mice showed higher performance improvement in the rotarod task 24 h or 4 days after initial training (p < 0.01 by t test, Figure 6E) . Notably, the improvement of rotarod performance positively correlated with the survival rate of training-related persistent new spines (p = 0.0042; r = 0.77, Figure 6F ), suggesting that activation of SST-INs can rescue spine instability and motor memory deficits induced by acute MPTP infusion.
DISCUSSION
In this study, we investigated the effects of acute MPTP treatment on synaptic plasticity and motor memory functions. Using two-photon microscopy, we found that a single injection of MPTP in adolescent mice destabilized dendritic spines on apical dendrites of L5PRNs in the motor cortex, which is associated with an increase of pyramidal neuron dendritic activity and a decrease of SST-IN activity. Notably, activation of SST-INs in the motor cortex following MPTP administration rescued pyramidal cell dendritic and synaptic deficits and preserved motor skill learning memory. Together, our results show that SST-IN dysfunction in the motor cortex plays an important role in synaptic and learning deficits induced by acute MPTP administration. As one parkinsonism-inducing agent, chronic MPTP exposure causes dopamine neuron degeneration, leading to learning and behavioral abnormalities (Guo et al., 2015; Halliday et al., 2014) . The current study reported that a single dose of MPTP (30 mg/kg) led to impaired retention of motor skills that were acquired before the MPTP exposure, in association with the loss of learning-related new synapse structure, hyperactivity of pyramidal neuron dendrites, and suppression of SST-IN activity. These results indicate that at early stage of PD, motor cortex dysfunction may form one pathological feature and that targeting SST-INs has the potency to retard the progression of motor syndromes.
Structural and functional synaptic plasticity in the primary motor cortex has been shown to be critical for motor skill learning and retention (Cichon and Gan, 2015; Xu et al., 2009; Yang et al., 2009 Yang et al., , 2014 . Previous studies reported that rotarod learning over 8 h in 1-month-old mice causes a 2%-4% increase in new spine formation in the motor cortex Yang et al., 2014) . Learning-induced new spines persist over days to weeks, and the survival of these new spines strongly correlates with the animals' performance on motor skill tasks. After acute MPTP administration, we observed a marked increase in dendritic spine dynamics and a substantial loss of learning-induced new spines. This rapid loss of dendritic spines after MPTP exposure may contribute to the impairments of motor skill retention in these mice. To capture the functional plasticity of cortical spines, we employed in vivo Ca 2+ imaging and observed a 3-fold increase in Ca 2+ activity in dendritic spines after MPTP injection. Previous studies in different neurological diseases, such as seizure ( linked overload of Ca 2+ to the shrinkage or elimination of dendritic spines. MPTP-induced loss of dendritic spines, therefore, could be attributed to the increased Ca 2+ transients in pyramidal neuron dendrites and spines. Moreover, we found that MPTP-induced dendritic Ca 2+ spikes are NMDA receptor dependent, as blockade of NMDA receptor with MK801 normalized dendritic activity in cortical pyramidal neurons. Together, these results suggest that cortical pyramidal neuron dendritic hyperactivity may contribute to MPTP-induced synapse loss and motor memory impairments.
The activities of pyramidal neurons in the cortex are regulated by a great variety of local inhibitory interneurons. Among them, SST-INs constitute 30% of all cortical interneurons (Urban-Ciecko and Barth, 2016). Although SST-INs themselves are a heterogeneous population and target different cells in different layers, they mainly innervate the distal portion of apical dendrites (Hattori et al., 2017; Muñ oz et al., 2017; Urban-Ciecko and Barth, 2016) . It has been shown that SST-INs regulate dendritic spine activity and dendritic Ca 2+ spike generation (Cichon et al., 2017; Cichon and Gan, 2015) . Consistent with the increase of dendritic activity in our acute MPTP administration model, we observed a rapid and substantial decrease of SST-IN (C) Representative dendritic segments from L5PRN apical tufts before rotarod skill learning (0), after learning and MPTP and/or CNO injection (8 h), and afterward (12-24 h). Filled arrowheads, newly formed spines at 8 h; asterisks, filopodia. Scale bar, 5 mm. (D) CNO injection enhanced the survival rates of newly formed spines within 8-to 12-h and 8-to 24-h time windows (8-12 h, t 6 = 6.35, p = 0.0007; 8-24 h, t 6 = 4.378, p = 0.0047; n = 4 per group). (E) Performance improvement (fold increase normalized to that in the learning session at 0 h) was elevated at 24 h and 4 days after initial learnings (24 h: t 6 = 4.099, p = 0.0064; 4 days: t 6 = 5.493, p = 0.0015). (F) Pearson correlation analysis showed positive correlation between new spine survival rates (0-8-24 h) and rotarod performance improvements at 24 h (r = 0.77; p = 0.0042). *p < 0.05. Data were presented as mean G SEM. activity within 60 min after MPTP infusion, which is in favor of dendritic hyperactivity. Interestingly, measures from postmortem brain of patients with PD-related dementia showed reduced SST immunoreactivity in the cortex (Allen et al., 1985; Beal et al., 1986; Epelbaum et al., 1983) , and decreased expression of SST in pluripotent stem cells derived from patients with Parkin mutations (Iwasawa et al., 2019) , supporting the involvement of SST-INs in PD pathogenesis.
Given the reduction of SST-IN activity after MPTP administration, we manipulated the activity of SST-INs using chemogenetic approach and showed that SST-IN activation in the motor cortex prevented MPTPinduced increase in dendritic Ca 2+ spike generation ( Figure S4) , dendritic spine loss, and motor memory impairments. Activation of GABAergic inhibitory interneurons in cortical circuits has been shown to be beneficial in treating multiple neurological disorders with the characteristic of cortical hyperexcitability, including major depressive disorder (Fee et al., 2017; Lin and Sibille, 2015) , neuropathic pain (Cichon et al., 2017) , AD (Schmid et al., 2016; Verret et al., 2012) , and PD (Lindenbach et al., 2016; Tyagi et al., 2015; Zhang et al., 2017) . It is worth to note that besides SST-INs, there are other types of interneurons located in the superficial layer of the cerebral cortex (Murphy et al., 2016) . These cells are known to target apical tuft dendrites, and their activation can suppress Ca 2+ spike generation in L5PRNs.
To explore the molecular mechanisms underlying MPTP-induced memory deficits, we examined the amounts of various proteins in the cortex after MPTP treatment, focusing on those involved in synaptic plasticity and function (Lee et al., 2009; Yasuda, 2017) . Previous studies have shown that activation of Ca 2+ /calmodulin-dependent kinase II (CaMKII) Lee et al., 2009; Lisman et al., 2012) and small GTPase proteins (Hedrick et al., 2016) facilitates the long-term potentiation of dendritic spines in hippocampal slices. Using western blot analysis, we found that MPTP injection had no significant effects on the total amounts of CaMKII in the brain but caused a marked reduction in the level of CaMKII phosphorylated at Thr-286 (p-CaMKII) when compared with vehicle-treated controls at 4-12 h ( Figure S5) . These results indicate that MPTP treatment acutely impairs CaMKII autophosphorylation in the cortex. Importantly, CNO treatment of SST-IRES-Cre mice infected with hM3Dq exhibited normal levels of p-CaMKII 4 h after MPTP injection, whereas the levels of cofilin, Ras1, RhoA, cdc42, and Rac1 remained unaltered ( Figure S5 ). CaMKII autophosphorylation is an important regulator of synaptic plasticity (Chang et al., 2017; Lee et al., 2009; Okamoto et al., 2007) , and its impairments have been observed in mouse hippocampus after acute or chronic MPTP infusion (Zhu et al., 2015) . More importantly, a recent study suggested that pharmacological inhibition of CaMKII phosphorylation can disrupt motor learning (Adler et al., 2019) . The fact that SST-IN activation also corrects CaMKII autophosphorylation further suggests that manipulating SST-IN activity could be an important approach for preventing cortical hyperexcitability and motor memory impairments.
In sum, our current work demonstrates rapidly hyperactivated dendritic spines in the motor cortex after acute MPTP infusion, in association with spine loss plus motor dysfunctions. The activation of SST-INs helps to relieve these pathological phenotypes to recover motor learning function. Future studies will be needed to examine whether other types of interneurons could also be targeted to protect synaptic loss and motor learning deficits in MPTP-treated mice.
Limitations of the Study
Our results demonstrate that potentiation of cortical SST-INs could relieve dendritic hyperactivity, spine loss, and motor learning deficits after acute MPTP injection. The current study, however, does not address if similar strategy can be used under chronic MPTP administration, which is one typical model of PD. Moreover, the long-term ameliorating effect from chemogenetics activation approach has not been evaluated. Further studies are thus required to address those issues to get a more complete picture of inhibitory transmission in motor cortical dysfunction.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.06.040. Ca 2+ spike amplitudes before and after MPTP injection. MPTP has no effect on the peak amplitude of dendritic Ca 2+ spikes (t 305 = 0.857, P = 0.6225; n = 5). ns, non-significant difference. Data were presented as mean ± s.e.m. Phosphorylated cofilin/ total cofilin, F (2, 9) = 0.1470, P = 0.8653; Ras1, F (2, 9) = 0.1568, P = 0.8571; RhoA (F(2, 9) = 0.0969, P = 0.9085; Cdc42, F (2, 9) = 0.8152, P = 0.4727; Rac1, F (2, 9) = 0.05478, P = 0.9470); n = 4 for each group. * P < 0.05. Data are presented as mean ± s.e.m.
Transparent Methods
Experimental animals
Thy1-yellow fluorescent protein (YFP) transgenic mice and SST-IRES-Cre mice were purchased from Jackson Laboratory, bred in-house, and were used for dendritic spine imaging and chemogenetic assays. Male C57BL/6J mice were purchased from Guangdong Medical Laboratory Animal Center and were used for all experiments.
For spine structural imaging (Fig. 1) , 30-day old male Thy1-YFP mice were used. For in vivo Ca 2+ imaging (Fig.2 to Fig. 4 ), male C57 mice (Fig.2 and Fig. 3 ) or SST-Cre mice (Fig. 4) received virus injection at P30, and were imaged 18 days later. In chemogenetic study ( Fig. 5 and Fig. 6 ), SST-Cre::Thy1-YFP mice (Fig. 5 ) or SST-Cre mice (Fig. 6) received combined virus injection at P30, and were imaged after 18 days.
All experimental animals were group-housed in the normal light-dark cycle (08:00-20:00 on light) with food and water ad libitum. In chemogenetics assays, CNO (2.5mg/kg) was applied by intraperitoneal injection. All experimental protocols have been pre-approved by the laboratory Animal Ethics Committee at Jinan University in accordance with IACUC guidelines for animal research.
Motor learning assays
All behavioral experiments were performed in a blinded manner. The rotarod task was performed using the Rotamex Rotarod apparatus (UGO Basile Mouse Rota-Rod 47700/600, Italy). During the learning phase, the mice were trained under an accelerating mode (2 to 80 rpm over the course 5 min) for multiple sessions until more than 50% improvements of latencies have been observed compared to those during the initial training session. The single retrieval test was performed at 24 h and 4 days later using the same parameter as the training sessions. The performance improvement is calculated as (Latency of test session -latency of training session) / Latency of training session.
In the beam walking test, a customized walking beam (70cm length, 6cm width) was connected with two-side chambers. The whole apparatus was placed 60 cm above the floor. The mouse was trained to walk cross the beam to reach the other chamber and the time duration on the beam was recorded. In general, the mice were trained for 3 or more consecutive sessions with 5 min interval to reach a stable performance without interruption during the beam-walking session. The memory retrieval session was performed 24 h later. The performance improvement was calculated as (Averaged crossing time in training sessions -crossing time in testing session) / Averaged crossing time in training sessions.
Stereotaxic injection of viral vectors
Genetically encoded calcium indicator GCaMP6s was packaged into adeno-associated virus (AAV, serotype 2/1, viral titer>2×10 13 genome copies per ml) under human synapsin (hSyn) promotor (Gene Therapy Program Vector Core, University of Pennsylvania). For stereotaxic injection, mice were anesthetized by intraperitoneal injection of 1.25% Avertin. The primary motor cortex (0.5 mm anterior to the Bregma and 1.2 mm lateral) was identified by a stereotaxic instrument (RWD, China). A high-speed microdrill was used to create an injection hole, through which 80-100 nl of AAV-hSyn-GCaMP6s vector was injected into the motor cortex at 25 nl per min velocity using glass micropipette connected to an ultra-micro injection pump (Nanoliter2010, WPI, USA) under a controller (Micro4, WPI, USA). The micropipette was retained in layer 5 (500-700 μm depth from the pia) for 10 min before retraction. A 60° injection angle was adopted to avoid damaging the neurons and dendrites of the imaging area. The Ca 2+ imaging assay was performed 18 days after virus injection. To monitor SST-IN activity, AAV-CAG-Flex-GCaMP6s (Serotype 2/1, viral titer > 2×10 13 genome copies per ml, Penn Vector Core) was injected into the primary motor cortex of SST-IRES-Cre mice. For chemogenetic manipulation assays, 200-300 nl of AAV-hSyn-DIO-hM3Dq-mCherry vector (Serotype 2/9, 2×10 12 genome copies per ml, Taitool BioScience Co, Shanghai) was bilaterally injected into the primary motor cortex of SST-IRES-Cre mice, and 80-100 nl of AAV-hSyn-GCaMP6s vector was separately injected into layer 5. For chemogentic coupled with spine imaging assays, 200 nl of AAV-hSyn-DIO-hM3Dq-mCherry vector were bilaterally injected into layer 2/3 of the primary motor cortex of Thy1-YFP::SST-IRES-Cre mice. The expression of the virus in the primary motor cortex was further validated by fixation, sectioning and fluorescence imaging after 2-photon microscopy.
In vivo two-photon imaging of spine structure and Ca 2+ spikes
The structural plasticity of dendritic spines was observed using the thin-skull approach. In brief, mice were anesthetized with 1.25% Avertin. Their eyes were protected by the eye ointment, the head hair was shaved, and the skull surface was exposed and cleaned. The primary motor cortex was identified by a stereotactic apparatus and marked. A double-sided blade was glued to the targeted imaging region and a customized stage was used to fix the skull. A circular imaging window was created by high-speed microdrill and microsurgical blade. The skull was covered with artificial cerebrospinal fluid (ACSF), and the mouse was placed on the stage of two-photon microscope (LSM780, Zeiss, Germany). Images of apical dendritic spines were captured under a water-immersed 20× objective (1.1NA) using 920 nm excitation wavelength for YFP. A low-magnification z-stacked image (1× digital zoom, 512 × 512 pixels) and the blood vessel map were recorded for the future re-imaging.
About seven high-magnification z-stacked images (4× digital zoom, 0.75 μm step size, 1024 × 1024 pixels) were acquired for dendritic spine quantification. One imaging session took ~30 min. After imaging, the mouse head was gently detached from the skull holder. The remaining glue was cleaned, and the scalp was sutured by surgical silk. Mice were returned to their own home cages for post-op recovery until the next imaging session.
For in vivo Ca 2+ imaging, the surgical procedures were performed 24 h in advance and a custom-made head holder was glued and attached to the skull. The dental acrylic cement was used to seal the reaming part of the skull except for the imaging region. After surgical recovery, the mouse was returned to their home cage for imaging.
To capture Ca 2+ activity of L5 PRN dendrites and SST-IN axons or somas, an imaging window was created by removing a small piece (2 mm × 2 mm) of skull above the motor cortex using a high-speed microdrill. The window was covered with a glass coverslip before imaging. Ca 2+ activities of both dendrites and somas were recorded at 2 Hz with a water-immersed 20× objective (1.1NA, 2× digital zoom) for 3 min and 2.5 min, respectively. During imaging, the laser power at 920 nm was less than 25 mW to prevent possible tissue injury or bleaching effects.
Local application of drugs
After imaging session, a small bone flap adjacent to the imaging window was removed by a high-speed microdrill. 200 nl of NMDAR antagonist MK801
(HY-15084, 10μM in ACSF, MedChemExpress, US) was applied onto the superficial layer with an angle of 60° using a micropipette. In general, the injection site was >100 μm away from imaging region to avoid tissue injury.
In the local administration assay, 100 μl MPTP (30 μM in the ACSF, HY-15608, MedChemExpress, US) was immersed onto the brain surface through the hole created by the high-speed microdrill with ~1 mm adjacent to the imaging window. The drug immersion lasted for ~30 min, followed by the re-imaging session.
Western blotting
Total protein samples were extracted from the motor cortex as abovementioned. The protein concentration was determined by a BCA kit (Beyotime, China). 10 μg/ml protein samples were mixed with 5X bromophenol blue at 4:1 ratio and boiled at 100 o C for 10 min before loading. 10% polyacrylamide gel (10% SDS, 1.5M Tris-Hcl, 40% acrylamide, APS and TEMED) was used for SDS-PAGE assays. In each well, 8
μl protein was loaded for 120 min electrophoresis, and protein samples were then 
